✦ LIBER ✦
140Safety, tolerability and drug interactions of adjuvant imatinib mesylate (GLEEVEC®) within the first 100 days following stem cell transplantation (SCT) in patients with PH+ CML and PH+ all at high risk for recurrence
✍ Scribed by S.R. Sheth; K. Hicks; C. Ippoliti; S. Giralt; R.E. Champlin; P. Anderlini
- Book ID
- 117728146
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- English
- Weight
- 137 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1083-8791
No coin nor oath required. For personal study only.